Foley Represents TCG Crossover as Lead Investor in KalVista Pharmaceuticals $58M Direct Offering

Foley & Lardner LLP represented TCG Crossover as the lead investor in KalVista Pharmaceuticals’ $58 million registered direct offering. KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule […]
A Look at Series A Financing Amidst the Downturn

Are we in a downturn? I am no economist, but in the global Silicon Valley, 2022 was all about the early stage in tech. Strong headwinds in financial markets, compressed multiples leading to substantially lower valuations, accelerating inflation and higher interest rates, war, pandemic and supply disruption, have been only some of the uncertainties that […]